ASK REDCHAT ANYTHING ABOUT 4D MOLECULAR THERAPEUTICS, INC.
4D Molecular Therapeutics, Inc. (NASDAQ: FDMT)
Listen to this Section
$12.74
+0.0540
(
+0.43% )
73.6K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| 4D-150DetailsDiabetic macular edema |
Phase 2 |
| 4D-310DetailsFabry disease |
Phase 1/2 |
| 4D-710DetailsCystic fibrosis |
Phase 1/2 |
| 4D-125DetailsX-linked retinitis pigmentosa |
Phase 1/2 |
| 4D-150DetailsWet age-related macular degeneration |
Phase 1/2 |
| 4D-110DetailsChoroideremia |
Phase 1 |
| 4D-175DetailsGeographic atrophy |
Phase 1 |
Market Data
|
| Open |
$12.74 |
| Previous Close |
$12.69 |
| Volume |
73.6K |
| Market Cap |
$695.27M |
| Day Range |
$12.70 - $12.85 |
| 52 Week Range |
$3.86 - $14.00 |
| Shares Outstanding |
52.28M |
| Change % |
+0.43% |
| Net Change |
▲ 0.0540 |
| Insider Ownership |
-0.36% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Year | 2020 |
| Country | United States |
| Underwriter | IPO Intelligence Only |
Insider Ownership Transactions
Total Amount Purchased:
-58,662.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-07-18 |
Sale |
-500.00 |
Bizily Scott |
| 2024-07-15 |
Sale |
-1996.00 |
Bizily Scott |
| 2024-07-12 |
Sale |
-11653.00 |
Kirn David |
| 2024-07-03 |
Sale |
-1332.00 |
Bizily Scott |
| 2024-06-26 |
Sale |
-12930.00 |
Kirn David |
| 2024-05-23 |
Sale |
-22500.00 |
GRAY SUSANNAH |
| 2024-05-20 |
Sale |
-500.00 |
Bizily Scott |
| 2024-04-18 |
Sale |
-500.00 |
Bizily Scott |
| 2024-03-29 |
Sale |
-4342.00 |
Bizily Scott |
| 2024-03-20 |
Sale |
-500.00 |
Bizily Scott |